Myasthenia Gravis: Which Test Is Best? When and Why?

Drs Nicholas Silvestri and Carolina Barnett-Tapia discuss what you need to know about immunopathogenesis and diagnosis for this relatively rare condition.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/989800). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196750/

Complement Inhibitor Therapy for Myasthenia Gravis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283905/

Spotlight on MuSK Positive Myasthenia Gravis: Clinical Characteristics, Treatment and Outcomes https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895578/

A Radioimmunoassay for the Quantitative Evaluation of Anti-human Acetylcholine Receptor Antibodies in Myasthenia Gravis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1541026/